JAJafar Aslani

Jafar Aslani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jafar Aslani has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of Aloe Vera and Pantoprazole on Gastroesophageal Reflux Symptoms in Mustard Gas Victims: A Randomized Controlled Trial

    by Yunes Panahi, Jafar Aslani, Ali Hajihashemi, Mahdieh Kalkhorani, Mostafa Ghanei, Amirhossein Sahebkar


  • Open Access

    A Triage Model for Chemical Warfare Casualties

    by Mohammad Ali Khoshnevis, Yunes Panahi, Mostafa Ghanei, Hojat Borna, Amirhossein Sahebkar, Jafar Aslani

    Context: The main objectives of triage are securing patient safety during the process of emergency diagnosis and treatment, and reduction of waiting time for medical services and transport. To date, there is no triage system for nerve agent victims. Evidence Acquisition: This systematic review proposes a new triage system for patients exposed to nerve agents. Information regarding clinical signs and symptoms of intoxication with nerve agents, primary treatments, and classification of patients were extracted from the literature. All related articles were reviewed. Subsequently, specialists from different disciplines were invited to discuss and draft protocols. Results: Finalized triage tables summarizing the classification methods and required protocols in the field were designed after several meetings. Conclusions: The proposed triage protocol encompasses aspects from most of the existing triage systems to create a single overarching guide for unifying the triage process. The proposed protocol can serve as a base for the designing future guidelines. Keywords: Triage; Chemical Warfare; Nerve Agents; Protocol


  • Helium:oxygen versus air:oxygen noninvasive positive-pressure ventilation in patients exposed to sulfur mustard

    by Mostafa Ghanei, Mohsen Rajaeinejad, Rouzbeh Motiei-Langroudi, Farshid Alaeddini, Jafar Aslani


    • 1 March 2011
      • Vol. 14  (2) , 86-90

    Correlation between the degree of air trapping in chest HRCT and cardiopulmonary exercise test parameters: could HRCT be a predictor of disease severity?

    by Mostafa Ghanei, Mohsen Sheyacy, Mohammad Amin Abbasi, Alireza Ani, Jafar Aslani

    The purpose of this study was to examine whether the degree of air trapping in high resolution computed tomography (HRCT) of patients with histories of sulfur mustard gas exposure during suspended full expiration correlated with various parameters of the cardiopulmonary exercise test as the gold standard for assessment of pulmonary function. In this analytic study 75 male patients, each with a history of sulfur mustard gas exposure, were investigated. Each participant underwent an incremental cardiopulmonary exercise test, pulmonary function test and arterial oxygen saturation for hemoglobin measurement. For HRCT examination, both lungs were divided into three parts (upper, middle, and lower) and in each part images were separately observed from the involved area point of view (25% ≥6/24). A total of 49.3% of the patients (37/75) had evidence of air trapping in over 25% of their lung segments. The mean age±SD in the patients with air trapping of =25% or <25% were 41.1±6.8 and 39.7±4.0 years, respectively (P=0.281). In our study there was no significant difference in pulmonary function test findings (FEV1, FVC and FEV1/FVC) between the two groups. There was no significant correlation with air trapping of =25% and any of the exercise test parameters. Also, no correlation was found between significant air trapping and exercise test findings in maximum exercise and anaerobic situations. No correlation was found between HRCT and cardiopulmonary exercise test findings. HRCT is neither pathognomic of the disease nor a good predictor of disease severity but it might be suggestive of mustard lung injuries.


  • Evaluation of activity and phenotype of α1-antitrypsin in a civil population with respiratory complications following exposure to sulfur mustard 20 years ago

    by Majid Shohrati, Navvab Shamspour, Fatemeh Babaei, Ali Amini Harandi, Afshin Mohsenifar, Jafar Aslani, Mostafa Ghanei

    Background and aims: The reduced α1-antitrypsin (AAT) activities of some phenotypes have been suggested as contributing to the development of respiratory diseases. Materials and methods: One hundred patients with respiratory disease following exposure to sulfur mustard were divided into two groups of 50 based on their respiratory symptoms and compared with a healthy control group. AAT phenotypes were determined in the plasma of all patient and control subjects by isoelectric focusing (IEF). Results: Mean AAT activities in patient and control groups were 3.4 ± 0.3 and 4.2 ± 0.1 μmol min−1 ml−1, respectively (p < 0.001). No phenotypic alterations were detected. Conclusions: The difference in the clinical pulmonary symptoms of the two groups was attributed to reduced AAT activity, but this was not manifested as phenotypic changes identifiable by IEF.


  • Evaluation of activity and phenotype of α1-antitrypsin in a civil population with respiratory complications following exposure to sulfur mustard 20 years ago

    by Majid Shohrati, Navvab Shamspour, Fatemeh Babaei, Ali Amini Harandi, Afshin Mohsenifar, Jafar Aslani, Mostafa Ghanei

  • Early Onset Emphysema in Smokers with Additional Exposure to Toxic Fumes; Occurrence and Diagnosis

    by Mostafa Ghanei, Shiva Alikhani, Iman Adibi, Mehdi Mir Mohamm, Taghi Ramazani, Jafar Aslani


    • 1 December 2007
      • Vol. 6  (4) , 207-14

    Clinical differentiation between resistant asthma and chronic bronchiolitis: testing a practical approach.

    by Mostafa Ghanei, Henry D Tazelaar, Ali Harandi, Mohammadreza Peyman, Hassan Mohammad Hoseini Akbari, Jafar Aslani

    Intractable asthma is a challenging clinical problem. This study was conducted to determine whether a subset of patients with Intractable asthma may be misdiagnosed and have a form of bronchiolitis instead and also to determine the effectiveness of macrolide therapy in these patients. Seventy six patients with Intractable asthma were re-treated with recommended maximal doses of oral prednisolone for 5 days, beclomethasone, cromolyn sodium, salbutamol and ipratropium bromide for 30 days. Thirty five patients were considered as unresponsive and constituted the study group. They underwent high-resolution CT (HRCT) scan following which they were offered with video-assisted thoracoscopic surgical biopsy. Group 1 (n= 27) refused biopsy and each was treated with macrolide therapy, while Group 2 (n=8) underwent biopsy, and then received macrolide therapy. The patients were treated and followed for three months. The study group consisted of 27 patients, with a mean age of 46.9 +/- 11.1 years. The mean duration of time between the onset of symptoms and the start of this study was 8.1 years. In group 2, no patient had pathologic findings of asthma, and 7/8 had a form of bronchiolitis. There was significant improvement in dyspnea, cough and pulmonary function indices at the end of the 3-month in both groups (p< 0.001). Our results suggest that patients with Intractable asthma could be misdiagnosed and some of them have some forms of chronic bronchiolitis. We believe that any patient who does not respond to standard treatments for Intractable asthma should be evaluated with expiratory HRCT; those with significant air trapping should be considered for a course of macrolide therapy or biopsy for better identification of the underlying disease.

    • 1 June 2005
      • Vol. 4  (2) , 83-90

    The therapeutic effect of gamma interferon in chronic bronchiolitis due to mustard gas.

    by Yunes Panahi, Mostafa Ghanei, Jafar Aslani, Mojtaba Mojtahedzadeh

    Bronchiolitis has been known as one of the pathological features of lung injuries in mustard gas exposed patients.The purpose of this research was to evaluate the efficacy of interferon gamma-1b on the lung function in mustard gas exposed patients with bronchiolitis. In multicenter research interferon gamma-1b was effective in pulmonary fibrosis with unknown reason, but assessment of effect of interferon gamma-1b in the chemical injured patients has not so far been reported.Thirty six patients with bronchiolitis whose lung lesion had been diagnosed through the chest high resolution computerized tomography (HRCT) and pathological study were divided into two eighteen member case and control groups. The case group was treated for 6 months with a combination of 200 mug of interferon gamma-1b (given three times per week subcutaneously) and 7.5mg of prednisolone (given once a day), while the control group received their previous medications (prednisolone 7.5mg/day + salbutamol and beclomethasone spray PRN).In the two groups, FEV1 did not have statistical differences at base line (49.3+/-2.9 and 48.7+/-4.1, respectively, p = 0.6), whereas after treatment the data for FEV1 showed a significant increase in the case group (66.3+/-5.4) when compared with those in the control group (57.3+/-8.6, p=0.001). The findings of this study indicate that a 6-month treatment with interferon gamma -1b plus a low-dose of prednisolone is associated with the improvement of the lung function in mustard gas exposed patients with bronchiolitis.